FDA Inspection 1227825 — Quinta-Analytica s.r.o. - Provozovna Brno

Quinta-Analytica s.r.o. - Provozovna Brno — FEI 3019851307

The FDA completed an inspection of Quinta-Analytica s.r.o. - Provozovna Brno on February 23, 2023 in Brno-Reckovice A Mokra Hora. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 23, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brno-Reckovice A Mokra Hora (Czech Republic)

Additional Details

Mutual Recognition Agreement (MRA)